C. Ola Landgren, Leader of Translational and Clinical Oncology Program/Experimental Therapeutics at Sylvester Comprehensive Cancer Center, shared on LinkedIn:
“To move closer to a cure for multiple myeloma, we need to understand not only why treatments work, but why they eventually stop working.
At the Sylvester Myeloma Institute at Sylvester Comprehensive Cancer Center, University of Miami, we are bringing together genomics, immunology, computational science and artificial intelligence to understand myeloma at unprecedented depth.
Our goal is to translate these discoveries into smarter clinical trials, more individualized treatment strategies, and ultimately curative therapies.
We are building a research program where discovery and clinical care continuously inform one another, accelerating the path from the laboratory to our patients.
Here in Miami, we are driving myeloma science forward with urgency, collaboration and optimism about what comes next.”
Make sure not to miss: Myeloma Paper of the Day, September 26th, Suggested by Robert Orlowski
